Phenotypic and mutational spectrum of 21 Chinese patients with Alström syndrome

2019 ◽  
Vol 182 (2) ◽  
pp. 279-288
Author(s):  
Kavitha Rethanavelu ◽  
Jasmine L. F. Fung ◽  
Jeffrey F. T. Chau ◽  
Steven L. C. Pei ◽  
Claudia C. Y. Chung ◽  
...  
2014 ◽  
Author(s):  
Jonathan Hazlehurst ◽  
Matthew Armstrong ◽  
Jayne Hodgkiss ◽  
Rachel Crowley ◽  
Tarekegn Geberhiwot ◽  
...  

Author(s):  
Yi Zhang ◽  
Tao Wang ◽  
Yan Wang ◽  
Kun Xia ◽  
Jinchen Li ◽  
...  

AbstractNeurodevelopmental disorders (NDDs) are a group of diseases characterized by high heterogeneity and frequently co-occurring symptoms. The mutational spectrum in patients with NDDs is largely incomplete. Here, we sequenced 547 genes from 1102 patients with NDDs and validated 1271 potential functional variants, including 108 de novo variants (DNVs) in 78 autosomal genes and seven inherited hemizygous variants in six X chromosomal genes. Notably, 36 of these 78 genes are the first to be reported in Chinese patients with NDDs. By integrating our genetic data with public data, we prioritized 212 NDD candidate genes with FDR < 0.1, including 17 novel genes. The novel candidate genes interacted or were co-expressed with known candidate genes, forming a functional network involved in known pathways. We highlighted MSL2, which carried two de novo protein-truncating variants (p.L192Vfs*3 and p.S486Ifs*11) and was frequently connected with known candidate genes. This study provides the mutational spectrum of NDDs in China and prioritizes 212 NDD candidate genes for further functional validation and genetic counseling.


Author(s):  
Midori Awazu ◽  
Tetsuya Tanaka ◽  
Seiji Sato ◽  
Makoto Anzo ◽  
Masataka Higuchi ◽  
...  

Genes ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 282
Author(s):  
Brais Bea-Mascato ◽  
Carlos Solarat ◽  
Irene Perea-Romero ◽  
Teresa Jaijo ◽  
Fiona Blanco-Kelly ◽  
...  

Alström syndrome (ALMS) is an ultrarare disease with an estimated prevalence lower than 1 in 1,000,000. It is associated with disease-causing mutations in the Alström syndrome 1 (ALMS1) gene, which codifies for a structural protein of the basal body and centrosomes. The symptomatology involves nystagmus, type 2 diabetes mellitus (T2D), obesity, dilated cardiomyopathy (DCM), neurodegenerative disorders and multiorgan fibrosis. We refined the clinical and genetic diagnosis data of 12 patients from 11 families, all of them from Spain. We also studied the allelic frequency of the different variants present in this cohort and performed a haplotype analysis for the most prevalent allele. The genetic analysis revealed 2 novel homozygous variants located in the exon 8, p.(Glu929Ter) and p.(His1808GlufsTer20) in 2 unrelated patients. These 2 novel variants were classified as pathogenic after an in silico experiment (computer analysis). On the other hand, 2 alleles were detected at a high frequency in our cohort: p.(Tyr1714Ter) (25%) and p.(Ser3872TyrfsTer19) (16.7%). The segregation analysis showed that the pathogenic variant p.(Tyr1714Ter) in 3 families is linked to a rare missense polymorphism, p.(Asn1787Asp). In conclusion, 2 novel pathological mutations have been discovered in homozygosis, as well as a probable founder effect in 3 unrelated families.


2000 ◽  
Vol 37 (3) ◽  
pp. 179-182
Author(s):  
Ping-I Chou ◽  
Chiao-Hong Chen ◽  
Jiann-Torng Chen ◽  
Liang-Yen Wen ◽  
Du-An Wu ◽  
...  

Eye ◽  
2008 ◽  
Vol 23 (5) ◽  
pp. 1210-1212 ◽  
Author(s):  
L Liu ◽  
B Dong ◽  
X Chen ◽  
J Li ◽  
Y Li

Author(s):  
Avijoy Roy Choudhury ◽  
Ifeanyi Munonye ◽  
Kevin Paul Sanu ◽  
Nipa Islam ◽  
Cecilia Gadaga

2006 ◽  
Vol 3 (1) ◽  
Author(s):  
Cahide Yılmaz ◽  
Hüseyin Çaksen ◽  
Nebi Yılmaz ◽  
Ahmet Sami Güven ◽  
Derya Arslan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document